Evidence map›Paper›PMID 33282748›Full record

ArticleFrontiers in cellular and infection microbiology2020

Dysbiotic Lesional Microbiome With Filaggrin Missense Variants Associate With Atopic Dermatitis in India.

Shankha Nath, Naina Kumari, Debabrata Bandyopadhyay, Neloy Sinha, Partha P Majumder, Rupak Mitra, Souvik Mukherjee

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Comparison of Colony-forming Units ofThe Journal of clinical and aesthetic dermatology · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Skin microbiota: pathogenic roles and implications in atopic dermatitis.Frontiers in cellular and infection microbiology · 2024
    Review
  7. Article
  8. Article
  9. The Role of the Cutaneous Mycobiome in Atopic Dermatitis.Journal of fungi (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Revisiting the Roles of Filaggrin in Atopic Dermatitis.International journal of molecular sciences · 2022
    Review
  12. Model-Based Meta-Analysis to OptimizeJID innovations : skin science from molecules to population health · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Targeted Filaggrin Gene (Indian dermatology online journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Shankha NathNational Institute of Biomedical Genomics, Kalyani, India.
Naina KumariNational Institute of Biomedical Genomics, Kalyani, India.
Debabrata BandyopadhyayMedical College and Hospital, Kolkata, India.
Neloy SinhaCollege of Medicine and JNM Hospital, Kalyani, India.
Partha P MajumderNational Institute of Biomedical Genomics, Kalyani, India.
Rupak MitraUnilever R & D, Bangalore, India.
Souvik MukherjeeNational Institute of Biomedical Genomics, Kalyani, India.
National Institute of Biomedical Genomics · INCollege of Medicine & JNM Hospital · INMedical College and Hospital, Kolkata · INUnilever (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dermatitis, AtopicMicrobiotaAdultChildDysbiosisFilaggrin ProteinsHumansIndiaIntermediate Filament ProteinsMalasseziaMutationMutation, MissenseS100 ProteinsFilaggrin ProteinsFLG protein, humanIntermediate Filament ProteinsS100 Proteinsatopic dermatitisFilaggrinhost-microbiome associationmicrobial pathwayskin microbiomeStaphylococcus aureus

Identifiers

PMID33282748
PMCPMC7705349
OpenAlexW3104360010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.